Seeking Alpha

FATE
  Fate Therapeutics, Inc. - NASDAQ

11/25/2014, 4:21 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FATE vs. ETF Alternatives
Company Description
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells. It has built two platforms: HSC modulation platform and Satellite Cell modulation platform.
Sector: Healthcare
Industry: Biotechnology
Country: United States